Summary
Date: 17 Feb 2020
The RACGP believes that there are a number of issues that need to be resolved before lung cancer screening is implemented in Australia. Lung cancer is a complex disease, with no clear target population for Low-Dose Tomography Screening (LDCT), little guidance on when to further investigate lesions, and overdiagnosis risks with associated harms.
There are also difficulties in reaching the high-risk populations, who already face barriers to screening, particularly those in rural and regional areas, and people with severe mental health issues.